New HIV prevention injection Lenacapavir will be available in Kenya from 2027 at Sh2,585 per shot for "low-income" populations

This follows a partnership between the Gates Foundation and Hetero Labs to offer a low-cost alternative to the original one produced by Gilead Sciences.